{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-23-017990","form_type":"8-K","ticker":"CRVO","cik":"0001053691","company_name":"CervoMed Inc.","filed_at":"2023-06-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:37.789368+00:00","generated_at":"2026-06-13T19:40:32.586830+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Diffusion Pharmaceuticals appoints General Counsel William Elder as principal financial officer","bullets":["William Elder, previously General Counsel and Corporate Secretary, appointed principal financial officer effective June 14, 2023.","No changes to Elder's existing employment agreement, equity awards, or compensation in connection with the appointment.","No arrangements or understandings with any other person regarding Elder's selection; no family relationships with directors or officers."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-23-017990","json":"https://secwatch.observer/filing/0001437749-23-017990.json","markdown":"https://secwatch.observer/filing/0001437749-23-017990.md","text":"https://secwatch.observer/filing/0001437749-23-017990.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1053691/000143774923017990/0001437749-23-017990-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1053691/000143774923017990/dffn20230621_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T19:40:32.586830+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"679b8f5188","claim":"William Elder was appointed as principal financial officer at CervoMed Inc..","evidence_excerpt":"On June 14, 2023, following the previously reported departure of the former Chief Financial Officer of Diffusion Pharmaceuticals Inc. (“Diffusion” or the “Company”), the Company’s board of directors appointed William Elder, Diffusion’s General Counsel and Corporate Secretary, as the Company’s principal financial officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774923017990/0001437749-23-017990-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"principal financial officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}